Advik Laboratories Share Price
|Managing Director||Peeyush Kumar Aggarwal|
|Independent Director||Manoj Kumar Jain|
|Company Secretary||Pooja Chuni|
|Independent Director||Madhu Sharma|
|Director||Ram Niwas Sharma|
Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The companys generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. Advik Laboratories Limited has a technical collaboration with PFC Pharma Focus Ltd. The company is based in New Delhi, India. It also markets its products in the Middle East, South America, and Africa. Advik Laboratories Limited was promoted in the 1994 by Jain along with a group of dedicated professionals. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality.During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2005-2006, the company bagged Govt. supply contracts from Govt. of Andhra Pradesh and Kerala Govt. for supply of Paracetamol. The company executed both the contracts on time.During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level.